Anzeige
Mehr »
Donnerstag, 12.02.2026 - Börsentäglich über 12.000 News
Top-Ergebnisse: 1,75 g/t Gold über 30,4 Meter + massives Tagebau-Potenzial
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESS Newswire
373 Leser
Artikel bewerten:
(1)

DPS Group Global: DPS Group Promotes Andy Wilkinson to Director of Aseptic Fill Finish

KANSAS CITY, MO / ACCESSWIRE / August 10, 2022 / DPS Group, a privately-owned, global engineering, procurement, construction management and validation (EPCMV) firm serving high-tech process industries, today announced it has promoted Andy Wilkinson to Director of Aseptic Fill Finish. Reporting to Werner Greyling, President of U.S. Project Operations, Andy will serve as a top-level technical expert on drug product technology and work on multiple projects and programs to support clients in the fill/finish and aseptic processing design space including feasibility, conceptual, and early BOD project phases. While Andy will be based in Kansas City, he will support all U.S. project operations in current DPS offices across the country and future West Coast locations.

DPS Group Global, Wednesday, August 10, 2022, Press release picture

"The promotion of Andy is a strategic move to add more subject matter experts to our leadership team, allowing us to better serve our clients and to develop our professional staff," said Werner. "DPS remains steadfast in its commitment to stay ahead of the curve related to new technologies and design processes."

With more than 30 years of experience leading projects in the pharmaceutical industry, Andy is the Aseptic Fill Finish subject matter expert for DPS. He is a recognized leader in aseptic processing design, aseptic filling, equipment/process design, installation, qualification, operation, and remediation. Andy uses his operational and technical experience to develop and implement solutions to achieve excellent client results. His blend of owner-side operations and consulting experience allow him to bring a unique perspective and understanding of clients' needs and market factors to each project. His depth of knowledge spans multiple sectors including human pharma, animal health, 503B compounding pharmacies, generic and branded products and small-scale start-ups.

Andy received a Bachelor of Arts in Interdisciplinary Studies / Biology from University of Missouri at Columbia. He is a member of the Parenteral Drug Association (PDA).

Serving high-tech industries around the world, DPS Group delivers full-service engineering across a range of disciplines, including project management, procurement, design, construction management, health and safety management, commissioning, qualification, and validation (CQV), and facility start-up.

About DPS Group

DPS Group is a global engineering, consulting and project management company, serving high-tech industries around the world. DPS delivers services for clients across the complete engineering and construction value chain including feasibility studies, concepts, consulting, architecture, engineering, procurement, construction management, commissioning, qualification, and validation as well as client-side technical services.

DPS applies its extensive process engineering expertise built over 47 years, as well as significant Lean construction experience to assist clients in high-end process sectors such as pharmaceuticals, biotech, and semiconductors to deliver manufacturing facilities speedily, safely, and cost effectively. What sets the firm apart is the partnerships it builds with clients through a fundamental understanding of their businesses and its own agility, flexibility, original thinking, and high-caliber people.

DPS has grown substantially in recent years and now employs more than 2,500 people in 18 offices and on client sites in Ireland, U.K., Netherlands, Belgium, Sweden, Switzerland, Israel, Singapore, Saudi Arabia, and the United States. For more information, visit www.dpsgroupglobal.com.

Media Contact:

Susan Shelby, FSMPS, CPSM
Rhino PR
978.985.4541
dps@rhinopr.com

SOURCE: DPS Group



View source version on accesswire.com:
https://www.accesswire.com/711283/DPS-Group-Promotes-Andy-Wilkinson-to-Director-of-Aseptic-Fill-Finish

© 2022 ACCESS Newswire
Favoritenwechsel
Das Börsenjahr 2026 ist für viele Anleger ernüchternd gestartet. Tech-Werte straucheln, der Nasdaq 100 tritt auf der Stelle und ausgerechnet alte Favoriten wie Microsoft und SAP rutschen zweistellig ab. KI ist plötzlich kein Rückenwind mehr, sondern ein Belastungsfaktor, weil Investoren beginnen, die finanzielle Nachhaltigkeit zu hinterfragen.

Gleichzeitig vollzieht sich an der Wall Street ein lautloser Favoritenwechsel. Während viele auf Wachstum setzen, feiern Value-Titel mit verlässlichen Cashflows ihr Comeback: Telekommunikation, Industrie, Energie, Pharma – die „Cashmaschinen“ der Realwirtschaft verdrängen hoch bewertete Hoffnungsträger.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die genau in dieses neue Marktbild passen: solide, günstig bewertet und mit attraktiver Dividende. Werte, die nicht nur laufende Erträge liefern, sondern auch bei Marktkorrekturen Sicherheit bieten.

Jetzt den kostenlosen Report sichern – bevor der Value-Zug 2026 endgültig abfährt!

Dieses exklusive PDF ist nur für kurze Zeit gratis verfügbar.
Diesen Artikel auf Deutsch lesen
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.